Smithfield Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Smithfield Trust’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15K	Sell	114 -5	-4%	-$624	﹤0.01%	834
2025 Q4	$15K	Buy	119 +5	+4%	+$573	﹤0.01%	828
2025 Q3	$11K	Hold	114	–	–	﹤0.01%	852
2025 Q2	$9K	Hold	114	–	–	﹤0.01%	886
2025 Q1	$9K	Hold	114	–	–	﹤0.01%	883
2024 Q4	$10K	Hold	114	–	–	﹤0.01%	874
2024 Q3	$11K	Hold	114	–	–	﹤0.01%	829
2024 Q2	$11K	Hold	114	–	–	﹤0.01%	810
2024 Q1	$11K	Hold	114	–	–	﹤0.01%	830
2023 Q4	$10K	Sell	114 -54	-32%	-$4.01K	﹤0.01%	833
2023 Q3	$12K	Hold	168	–	–	﹤0.01%	782
2023 Q2	$13K	Hold	168	–	–	﹤0.01%	785
2023 Q1	$13K	Buy	168 +114	+211%	+$9.46K	﹤0.01%	747
2022 Q4	$4K	Hold	54	–	–	﹤0.01%	926
2022 Q3	$4K	Buy	+54	New	+$4.55K	﹤0.01%	959

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Smithfield Trust's XBI Position: Q1 2026 in Review

Smithfield Trust reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 4.2% in Q1 2026, selling an estimated $624 and leaving 114 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #834.

Smithfield Trust first reported a position in XBI in Q3 2022 and has held it in 15 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Smithfield Trust held 114 shares of State Street SPDR S&P Biotech ETF worth $15K as of Q1 2026.
Smithfield Trust sold 5 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $624.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Smithfield Trust's portfolio in Q1 2026, its #834 holding.
Smithfield Trust first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and has held it in 15 quarters since.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.